WallStreetZenWallStreetZen

NASDAQ: SRTS
Sensus Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SRTS

Based on 1 analyst offering 12 month price targets for Sensus Healthcare Inc

Min Forecast
$6.00+97.37%
Avg Forecast
$6.00+97.37%
Max Forecast
$6.00+97.37%

Should I buy or sell SRTS stock?

Based on 1 analyst offering ratings for Sensus Healthcare Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SRTS stock forecasts and price targets.

SRTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-17

1 of 1

Forecast return on equity

Is SRTS forecast to generate an efficient return?

Company
3.69%
Industry
14.93%
Market
146.75%
SRTS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRTS forecast to generate an efficient return on assets?

Company
3.26%
Industry
12.28%
SRTS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRTS earnings per share forecast

What is SRTS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.02
Avg 3 year Forecast
$0.10

SRTS revenue forecast

What is SRTS's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$25.8M+14.46%
Avg 2 year Forecast
$34.2M+51.7%
Avg 3 year Forecast
$37.3M+65.68%
SRTS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SRTS revenue growth forecast

How is SRTS forecast to perform vs Medical Devices companies and vs the US market?

Company
20.23%
Industry
8.61%
Market
15.46%
SRTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SRTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SRTS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SRTS$3.04$6.00+97.37%Strong Buy
QTI$4.07N/AN/A
COCH$0.67$2.50+275.38%Buy
MOVE$24.46N/AN/A
LUNG$1.25$9.50+660.00%Strong Buy
View Top Medical Device Stocks

Sensus Healthcare Stock Forecast FAQ

Is Sensus Healthcare Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SRTS) stock is to Strong Buy SRTS stock.

Out of 1 analyst, 1 (100%) are recommending SRTS as a Strong Buy, 0 (0%) are recommending SRTS as a Buy, 0 (0%) are recommending SRTS as a Hold, 0 (0%) are recommending SRTS as a Sell, and 0 (0%) are recommending SRTS as a Strong Sell.

If you're new to stock investing, here's how to buy Sensus Healthcare stock.

What is SRTS's earnings growth forecast for 2026-2028?

(NASDAQ: SRTS) Sensus Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.83%.

Sensus Healthcare's earnings in 2026 is -$7,773,000.On average, 6 Wall Street analysts forecast SRTS's earnings for 2026 to be -$4,925,448, with the lowest SRTS earnings forecast at -$6,453,127, and the highest SRTS earnings forecast at -$2,592,774. On average, 6 Wall Street analysts forecast SRTS's earnings for 2027 to be -$279,855, with the lowest SRTS earnings forecast at -$3,710,548, and the highest SRTS earnings forecast at $4,839,845.

In 2028, SRTS is forecast to generate $1,679,130 in earnings, with the lowest earnings forecast at $1,613,282 and the highest earnings forecast at $1,728,516.

What is SRTS's revenue growth forecast for 2026-2028?

(NASDAQ: SRTS) Sensus Healthcare's forecast annual revenue growth rate of 20.23% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.46%.

Sensus Healthcare's revenue in 2026 is $22,532,000.On average, 6 Wall Street analysts forecast SRTS's revenue for 2026 to be $424,556,502, with the lowest SRTS revenue forecast at $359,366,748, and the highest SRTS revenue forecast at $508,183,761. On average, 6 Wall Street analysts forecast SRTS's revenue for 2027 to be $562,689,639, with the lowest SRTS revenue forecast at $468,049,261, and the highest SRTS revenue forecast at $781,289,320.

In 2028, SRTS is forecast to generate $614,545,125 in revenue, with the lowest revenue forecast at $559,775,854 and the highest revenue forecast at $665,478,735.

What is SRTS's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: SRTS) forecast ROA is 3.26%, which is lower than the forecast US Medical Devices industry average of 12.28%.

What is SRTS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SRTS price target, the average SRTS price target is $6.00, with the highest SRTS stock price forecast at $6.00 and the lowest SRTS stock price forecast at $6.00.

The Wall Street analyst predicted that Sensus Healthcare's share price could reach $6.00 by Feb 17, 2027. The average Sensus Healthcare stock price prediction forecasts a potential upside of 97.37% from the current SRTS share price of $3.04.

What is SRTS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SRTS) Sensus Healthcare's current Earnings Per Share (EPS) is -$0.47. On average, analysts forecast that SRTS's EPS will be -$0.30 for 2026, with the lowest EPS forecast at -$0.39, and the highest EPS forecast at -$0.16. On average, analysts forecast that SRTS's EPS will be -$0.02 for 2027, with the lowest EPS forecast at -$0.23, and the highest EPS forecast at $0.29. In 2028, SRTS's EPS is forecast to hit $0.10 (min: $0.10, max: $0.11).

What is SRTS's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: SRTS) forecast ROE is 3.69%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.